About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 574 record(s)
Req # A-2020-001924
Adverse Reaction Reports (AERs) for Abilify. Report numbers: E2B_03452264, E2B_03452286, E2B_03452288, E2B_03452296, E2B_03452301, E2B_03452302, E2B_03452319, E2B_03452360, E2B_03452382, E2B_03452517, E2B_03452588, E2B_03459113, E2B_03459121,…Organization: Health Canada
June 2021
Req # A-2020-001871
Adverse Drug Reaction (ADR) for Leflunomide. Report number: 000726887.Organization: Health Canada
June 2021
Req # A-2020-001878
Adverse Reaction Reports (AERs). Report numbers: E2B_03425677, E2B_03071666, E2B_03517209, E2B_03088216, E2B_03110552, E2B_03451303, E2B_03420640, E2B_03467188, E2B_03188480, E2B_03452634, E2B_03427733, E2B_03339482, E2B_03423249, E2B_03406161,…Organization: Health Canada
June 2021
Req # A-2020-001876
Adverse Reaction Reports (AERs) for C1 Esterase Inhibitor (Human). Report numbers: E2B_03501587, E2B_03454679, E2B_03474145, E2B_03484753, E2B_03424986, E2B_03424957. (ADRs) for Gammagard Liquid. Report numbers: 925469, 925764.Organization: Health Canada
June 2021
Req # A-2020-001884
Adverse Reaction Reports (AERs) for Mezavant. Report numbers: 927241, E2B_03486671, E2B_03510421, 926096.Organization: Health Canada
June 2021
Req # A-2020-001604
Adverse Drug Reaction (ADR). Report number: E2B_03380048.Organization: Health Canada
June 2021
Req # A-2020-001614
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115590-809.Organization: Health Canada
June 2021
Req # A-2020-001635
Adverse Reaction Reports (AERs) for LEFLUNOMIDE. Report numbers: 000913577, E2B_03214632, E2B_03215718, E2B_03218350, E2B_03227409, E2B_03231261, E2B_03183113, E2B_03183307, E2B_03183699, E2B_03223223, E2B_03239299, E2B_03229681, E2B_03241999,…Organization: Health Canada
June 2021
Req # A-2020-001656
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: 000918215, E2B_03171856, E2B_03190898, E2B_03191589, E2B_03200115, E2B_03203491, E2B_03226836, E2B_03234979, E2B_03258256, E2B_03234218, E2B_03239053, E2B_03240182,…Organization: Health Canada
June 2021
Req # A-2021-000030
Adverse Reaction Reports (AERs) for Baclofen. Report numbers: E2B_02869946, E2B_02768927, E2B_02753947.Organization: Health Canada
June 2021